<?xml version="1.0" encoding="UTF-8"?>
<p>This case report highlights the clinical impact of ACS‐STEMI in COVID‐19 patients. High levels of proinflammatory and hyperthrombotic activity could significantly affect the final outcome, even in young patients without cardiac past history or significant comorbidities.</p>
